As of Feb 12
| +0.08 / +0.67%|
The 8 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 22.50, with a high estimate of 29.00 and a low estimate of 14.00. The median estimate represents a +87.34% increase from the last price of 12.01.
The current consensus among 8 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.